is a global, fast-growing diagnostic company that brings energy and ingenuity to a world in dire need of rapid infection diagnosis. The company is headquartered in the UK and in Marlborough, Massachusetts.
Oxford Immunotec has developed a unique technology to confirm the diagnosis using ELISPOT assays measuring T cells.
The T-SPOT.TV test is the company’s flagship product for diagnosing tuberculosis, one of the most common causes of death from infectious diseases.
The company carries out tests in compliance with the Quality Management System, which ensures strict control of all batches.
To date, more than 20 million clinical T-cell tests for tuberculosis infection have been manufactured.
T-SPOT.TB is approved in more than 50 countries around the world, including FDA in the United States and CE in Europe.